Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$34.32 - $57.55 $5,594 - $9,380
-163 Reduced 0.95%
16,972 $949,000
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $168,343 - $259,477
4,120 Added 31.66%
17,135 $706,000
Q2 2023

Aug 14, 2023

BUY
$50.96 - $58.72 $663,244 - $764,240
13,015 New
13,015 $726,000
Q4 2022

Feb 14, 2023

BUY
$24.4 - $41.3 $1.03 Million - $1.74 Million
42,093 New
42,093 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.